,ID,Name,PharmaActions,InChIKey
0,108007,cobaltiprotoporphyrin,,AQTFKGDWFRRIHR-UHFFFAOYSA-L
1,9639,perflexane,,ZJIJAJXFLBMLCK-UHFFFAOYSA-N
2,12699,Methylnitrosourea,Noxae;Pharmacologic Actions;Alkylating Agents;Toxic Actions;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action,ZRKWMRDKSOPRRS-UHFFFAOYSA-N
3,2578,Carmustine,"Toxic Actions;Antineoplastic Agents, Alkylating;Antineoplastic Agents;Molecular Mechanisms of Pharmacological Action;Noxae;Pharmacologic Actions;Chemical Actions and Uses;Alkylating Agents;Therapeutic Uses",DLGOEMSEDOSKAD-UHFFFAOYSA-N
4,134018,Febuxostat,Gout Suppressants;Chemical Actions and Uses;Therapeutic Uses;Antirheumatic Agents;Pharmacologic Actions,BQSJTQLCZDPROO-UHFFFAOYSA-N
5,114778,kahweol,,JEKMKNDURXDJAD-HWUKTEKMSA-N
6,156418,Cinacalcet,"Calcium-Regulating Hormones and Agents;Chemical Actions and Uses;Hormone Antagonists;Physiological Effects of Drugs;Pharmacologic Actions;Hormones, Hormone Substitutes, and Hormone Antagonists;Calcimimetic Agents",QANQWUQOEJZMLL-PKLMIRHRSA-N
7,2477,Buspirone,Anti-Anxiety Agents;Central Nervous System Agents;Central Nervous System Depressants;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Neurotransmitter Agents;Pharmacologic Actions;Physiological Effects of Drugs;Psychotropic Drugs;Serotonin Agents;Serotonin Receptor Agonists;Therapeutic Uses;Tranquilizing Agents,QWCRAEMEVRGPNT-UHFFFAOYSA-N
8,104798,,,PWYYWQHXAPXYMF-UHFFFAOYSA-N
9,6597,Dichloroacetic Acid,,JXTHNDFMNIQAHM-UHFFFAOYSA-N
10,1104,,,WWUZIQQURGPMPG-UHFFFAOYSA-N
11,24812758,Canagliflozin,Sodium-Glucose Transporter 2 Inhibitors;Physiological Effects of Drugs;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Hypoglycemic Agents,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N
12,9975530,,,GMTJIWUFFXGFHH-RRROMXSMSA-N
13,52944803,,,LQRJAEQXMSMEDP-XCHBZYMASA-N
14,6518,Pentaerythritol Tetranitrate,Chemical Actions and Uses;Therapeutic Uses;Vasodilator Agents;Cardiovascular Agents;Pharmacologic Actions,TZRXHJWUDPFEEY-UHFFFAOYSA-N
15,65238,beta-penta-O-galloyl-glucose,,QJYNZEYHSMRWBK-NIKIMHBISA-N
16,9964357,,,LTJBOUZUHSXYCG-UHFFFAOYSA-J
17,27661,isosorbide-5-mononitrate,Therapeutic Uses;Chemical Actions and Uses;Nitric Oxide Donors;Vasodilator Agents;Molecular Mechanisms of Pharmacological Action;Cardiovascular Agents;Pharmacologic Actions,YWXYYJSYQOXTPL-SLPGGIOYSA-N
18,6169,Yohimbine,Adrenergic alpha-Antagonists;Physiological Effects of Drugs;Peripheral Nervous System Agents;Adrenergic Agents;Urological Agents;Adrenergic Antagonists;Adrenergic alpha-2 Receptor Antagonists;Neurotransmitter Agents;Chemical Actions and Uses;Autonomic Agents;Molecular Mechanisms of Pharmacological Action;Therapeutic Uses;Mydriatics;Pharmacologic Actions,PIPZGJSEDRMUAW-VJDCAHTMSA-N
19,11520587,"bis-1,3-((5,6-dihydro-5,11-diketo-11H-indeno(1,2-c)isoquinoline)-6-propylamino)propane",Chemical Actions and Uses;Therapeutic Uses;Topoisomerase I Inhibitors;Topoisomerase Inhibitors;Antineoplastic Agents;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions,LFBROBFDCPLXOA-UHFFFAOYSA-N
20,5358116,trimethyltin,,LYRCQNDYYRPFMF-UHFFFAOYSA-N
21,72276,Catechin,,PFTAWBLQPZVEMU-UKRRQHHQSA-N
22,442504,"(1R,5S)-4-methyl-1-propan-2-ylbicyclo(3.1.0)hex-3-en-2-one",,LTTVJAQLCIHAFV-WCBMZHEXSA-N
23,9815560,Streptokinase,Cardiovascular Agents;Fibrin Modulating Agents;Fibrinolytic Agents;Hematologic Agents;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Therapeutic Uses;Chemical Actions and Uses,XRZWVSXEDRYQGC-UHFFFAOYSA-N
24,9987061,,,BBAOHIALRKLBRD-OZDPOCAXSA-N
25,56841561,,,HROMYAWHLUOUPY-GOONNFATSA-N
26,3645619,N-((4-(2-cyanophenyl)-1-piperazinyl)methyl)-3-methylbenzamide,,DNULYRGWTFLJQL-UHFFFAOYSA-N
27,5944,Cantharidin,Pharmacologic Actions;Specialty Uses of Chemicals;Irritants;Chemical Actions and Uses;Enzyme Inhibitors;Noxae;Toxic Actions;Molecular Mechanisms of Pharmacological Action,DHZBEENLJMYSHQ-XCVPVQRUSA-N
28,11158353,"N-(2-(3-chloro-5-(trifluoromethyl)-2-pyridyl)ethyl)-alpha,alpha,alpha-trifluoro-o-toluamide",,KVDJTXBXMWJJEF-UHFFFAOYSA-N
29,24154,Galactosamine,,MSWZFWKMSRAUBD-GASJEMHNSA-N
30,5282253,domoic acid,Chemical Actions and Uses;Neuromuscular Blocking Agents;Pharmacologic Actions;Neuromuscular Agents;Physiological Effects of Drugs;Peripheral Nervous System Agents;Neuromuscular Depolarizing Agents,VZFRNCSOCOPNDB-AOKDLOFSSA-N
31,16738692,,,GUBXYMKIJFOYOA-YMGPVYFXSA-N
32,91516,ethylphenylpropiolate,,ACJOYTKWHPEIHW-UHFFFAOYSA-N
33,115114,"2-(2,3-dicarboxycyclopropyl)glycine",Pharmacologic Actions;Anticonvulsants;Central Nervous System Agents;Chemical Actions and Uses;Therapeutic Uses,MATPZHBYOVDBLI-IDPZHQIBSA-N
34,114827,eglumetad,Neurotransmitter Agents;Psychotropic Drugs;Pharmacologic Actions;Excitatory Amino Acid Agents;Central Nervous System Depressants;Central Nervous System Agents;Physiological Effects of Drugs;Therapeutic Uses;Anti-Anxiety Agents;Chemical Actions and Uses;Excitatory Amino Acid Agonists;Molecular Mechanisms of Pharmacological Action;Tranquilizing Agents,VTAARTQTOOYTES-UHFFFAOYSA-N
35,442786,,,FSBUXLDOLNLABB-WZJPPVJYSA-N
36,1352,1-(5-isoquinolinylsulfonyl)-3-methylpiperazine,Chemical Actions and Uses;Protein Kinase Inhibitors;Pharmacologic Actions;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action,QGSCXAWTTISKLF-UHFFFAOYSA-N
37,6328166,,,PBHCGFAQTBPLFW-UHFFFAOYSA-N
38,15667210,,,XETARULVTCYJAN-XLPZGREQSA-N
39,340211,latifolin,,OJVQOGDGFIJYPN-LLVKDONJSA-N
40,61671,Vanadates,,IHIXIJGXTJIKRB-UHFFFAOYSA-N
41,108018,N-chlorotaurine,Chemical Actions and Uses;Anti-Infective Agents;Antiviral Agents;Therapeutic Uses;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions,NMMHHSLZJLPMEG-UHFFFAOYSA-N
42,1381,,,YBCDZAGHRGXDRX-UHFFFAOYSA-N
43,5282259,"10-nitro-9,12-octadecadienoic acid",,LELVHAQTWXTCLY-XYWKCAQWSA-N
44,6434544,"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid",Pharmacologic Actions;Vasoconstrictor Agents;Therapeutic Uses;Cardiovascular Agents;Chemical Actions and Uses,LQANGKSBLPMBTJ-WTPHSRJXSA-N
45,2949,,,POZRVZJJTULAOH-UHFFFAOYSA-N
46,74493,,,CBOJBBMQJBVCMW-NQZVPSPJSA-N
47,3410,Formoterol Fumarate,Adrenergic beta-2 Receptor Agonists;Anti-Asthmatic Agents;Adrenergic Agonists;Autonomic Agents;Adrenergic Agents;Physiological Effects of Drugs;Respiratory System Agents;Therapeutic Uses;Bronchodilator Agents;Peripheral Nervous System Agents;Adrenergic beta-Agonists;Neurotransmitter Agents;Chemical Actions and Uses;Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action,BPZSYCZIITTYBL-UHFFFAOYSA-N
48,38024,"2,3,6,2',3',6'-hexachlorobiphenyl",,FZFUUSROAHKTTF-UHFFFAOYSA-N
49,637858,piperlonguminine,,VABYUUZNAVQNPG-BQYQJAHWSA-N
50,14584,fencamfamine,Antipsychotic Agents;Central Nervous System Depressants;Central Nervous System Agents;Central Nervous System Stimulants;Pharmacologic Actions;Tranquilizing Agents;Therapeutic Uses;Chemical Actions and Uses;Psychotropic Drugs;Physiological Effects of Drugs,IKFBPFGUINLYQI-UHFFFAOYSA-N
51,3033825,Simendan,Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Chemical Actions and Uses;Phosphodiesterase Inhibitors;Therapeutic Uses;Phosphodiesterase 3 Inhibitors;Specialty Uses of Chemicals;Enzyme Inhibitors;Vasodilator Agents;Protective Agents;Cardiovascular Agents;Cardiotonic Agents,WHXMKTBCFHIYNQ-SECBINFHSA-N
52,42742,,,GKVUDAZMZLMNJQ-UHFFFAOYSA-N
53,3084046,sephadex,Laboratory Chemicals;Specialty Uses of Chemicals;Indicators and Reagents;Chemical Actions and Uses,BCPVZFFJGCURNR-OCOFDJSDSA-N
54,32800,,,IZTQOLKUZKXIRV-UHFFFAOYSA-N
55,53399048,,,LSKCTKMTYNICJW-UHFFFAOYSA-N
56,5497107,G(M1) Ganglioside,,QPJBWNIQKHGLAU-BVLUPYCXSA-N
57,3331970,"4-aminopyrrolidine-2,4-dicarboxylic acid",,XZFMJVJDSYRWDQ-UHFFFAOYSA-N
58,5311246,ONO 1301,,WBBLIRPKRKYMTD-UHFFFAOYSA-N
59,2349,Penicillins,Anti-Bacterial Agents;Anti-Infective Agents;Therapeutic Uses;Pharmacologic Actions;Chemical Actions and Uses,JGSARLDLIJGVTE-UHFFFAOYSA-N
60,6918876,,,FFXUDLUXUIJFSS-NTCAYCPXSA-N
61,114739,"2,3-bis(3'-hydroxybenzyl)butyrolactone","Estrogens, Non-Steroidal;Physiological Effects of Drugs;Hormones, Hormone Substitutes, and Hormone Antagonists;Phytoestrogens;Pharmacologic Actions;Hormones;Chemical Actions and Uses;Estrogens",HVDGDHBAMCBBLR-PBHICJAKSA-N
62,9848818,tauroursodeoxycholic acid,Cholagogues and Choleretics;Therapeutic Uses;Gastrointestinal Agents;Antiviral Agents;Anti-Infective Agents;Pharmacologic Actions;Chemical Actions and Uses,BHTRKEVKTKCXOH-LBSADWJPSA-N
63,93504,Cromakalim,Autonomic Agents;Bronchodilator Agents;Chemical Actions and Uses;Antihypertensive Agents;Therapeutic Uses;Pharmacologic Actions;Vasodilator Agents;Anti-Asthmatic Agents;Respiratory System Agents;Cardiovascular Agents;Peripheral Nervous System Agents;Physiological Effects of Drugs;Parasympatholytics,TVZCRIROJQEVOT-CABCVRRESA-N
64,28417,Danazol,"Hormones, Hormone Substitutes, and Hormone Antagonists;Physiological Effects of Drugs;Hormone Antagonists;Pharmacologic Actions;Estrogen Antagonists;Chemical Actions and Uses",POZRVZJJTULAOH-LHZXLZLDSA-N
65,6918522,omtriptolide,,HROMYAWHLUOUPY-AHCCQAQQSA-N
66,311,Citric Acid,Anticoagulants;Calcium Chelating Agents;Chelating Agents;Chemical Actions and Uses;Hematologic Agents;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Sequestering Agents;Specialty Uses of Chemicals;Therapeutic Uses,KRKNYBCHXYNGOX-UHFFFAOYSA-N
67,1209,,,ASNFTDCKZKHJSW-UHFFFAOYSA-N
68,656486,,,YWRFBISQAMHSIX-UHFFFAOYSA-N
69,92398,NSC 354646,,SXCIMUIAZXOVIR-PUCKCBAPSA-N
70,5618,"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid",Cardiovascular Agents;Chemical Actions and Uses;Pharmacologic Actions;Therapeutic Uses;Vasoconstrictor Agents,LQANGKSBLPMBTJ-UHFFFAOYSA-N
71,105089,beta-N-methylamino-L-alanine,Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Excitatory Amino Acid Agents;Pharmacologic Actions;Physiological Effects of Drugs;Excitatory Amino Acid Agonists;Neurotransmitter Agents,UJVHVMNGOZXSOZ-VKHMYHEASA-N
72,9857255,"2-((2'-amino)propionyl)aminobicyclo(3.1.0)hexane-2,6-dicarboxylic acid",,TWZDLCLCMKMJPE-OAOSNHGPSA-N
73,637760,Chalcone,,DQFBYFPFKXHELB-VAWYXSNFSA-N
74,6989,Thymol,"Pharmacologic Actions;Anti-Infective Agents, Local;Antifungal Agents;Chemical Actions and Uses;Anti-Infective Agents;Therapeutic Uses",MGSRCZKZVOBKFT-UHFFFAOYSA-N
75,2937,"9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2",Anti-Infective Agents;Antineoplastic Agents;Antiviral Agents;Chemical Actions and Uses;Pharmacologic Actions;Therapeutic Uses,TUXFWOHFPFBNEJ-UHFFFAOYSA-N
76,6360,,,NNPPMTNAJDCUHE-UHFFFAOYSA-N
77,5273755,eupatilin,,DRRWBCNQOKKKOL-UHFFFAOYSA-N
78,3478,Glipizide,Hypoglycemic Agents;Chemical Actions and Uses;Pharmacologic Actions;Physiological Effects of Drugs,ZJJXGWJIGJFDTL-UHFFFAOYSA-N
79,71157,nefiracetam,Nootropic Agents;Physiological Effects of Drugs;Protective Agents;Central Nervous System Agents;Chemical Actions and Uses;Psychotropic Drugs;Pharmacologic Actions;Neuroprotective Agents;Therapeutic Uses,NGHTXZCKLWZPGK-UHFFFAOYSA-N
80,19665,Butylhydroxybutylnitrosamine,,DIKPQFXYECAYPC-UHFFFAOYSA-N
81,1233,Ibotenic Acid,Molecular Mechanisms of Pharmacological Action;Physiological Effects of Drugs;Excitatory Amino Acid Agents;Pharmacologic Actions;Excitatory Amino Acid Agonists;Neurotransmitter Agents;Chemical Actions and Uses,IRJCBFDCFXCWGO-UHFFFAOYSA-N
82,15487,denatonium,Aversive Agents;Chemical Actions and Uses;Specialty Uses of Chemicals;Molecular Mechanisms of Pharmacological Action;Physiological Effects of Drugs;Peripheral Nervous System Agents;Central Nervous System Agents;Therapeutic Uses;Abuse-Deterrent Formulations;Pharmaceutical Preparations;Sensory System Agents;Pharmacologic Actions;Pharmaceutic Aids,YNQALPDYZRNHNK-UHFFFAOYSA-N
83,2545,,,DHZBEENLJMYSHQ-UHFFFAOYSA-N
84,5280353,Biliverdine,,RCNSAJSGRJSBKK-NSQVQWHSSA-N
85,2826713,KRN 7000,"Chemical Actions and Uses;Adjuvants, Immunologic;Physiological Effects of Drugs;Immunologic Factors;Antineoplastic Agents;Therapeutic Uses;Pharmacologic Actions",VQFKFAKEUMHBLV-BYSUZVQFSA-N
86,11635,octadecane,,RZJRJXONCZWCBN-UHFFFAOYSA-N
87,115010,,,MSLKMRUEVOYOOZ-UHFFFAOYSA-L
88,3477,,,FIVPIPIDMRVLAY-UHFFFAOYSA-N
89,158796,N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine,,YJXUXANREVNZLH-PFEQFJNWSA-N
90,91754599,,,HSOKCKRDVRKPGT-LLVKDONJSA-N
91,65684,dicarbine,Central Nervous System Depressants;Anti-Arrhythmia Agents;Chemical Actions and Uses;Central Nervous System Agents;Teratogens;Antipsychotic Agents;Noxae;Cardiovascular Agents;Protective Agents;Physiological Effects of Drugs;Antioxidants;Psychotropic Drugs;Molecular Mechanisms of Pharmacological Action;Tranquilizing Agents;Pharmacologic Actions;Toxic Actions;Specialty Uses of Chemicals;Antimutagenic Agents;Therapeutic Uses,CYJQCYXRNNCURD-UHFFFAOYSA-N
92,3180,dyclonine,"Anesthetics;Chemical Actions and Uses;Peripheral Nervous System Agents;Pharmacologic Actions;Physiological Effects of Drugs;Central Nervous System Depressants;Sensory System Agents;Anesthetics, Local;Central Nervous System Agents;Therapeutic Uses",BZEWSEKUUPWQDQ-UHFFFAOYSA-N
93,637394,hirsutanone,,VWHYFMQKJYFLCC-DUXPYHPUSA-N
94,4972,,,AQTFKGDWFRRIHR-UHFFFAOYSA-L
95,6850753,,,WHJKCPTVEYZNOG-UHFFFAOYSA-N
96,8830,"2,4-dinitrofluorobenzene sulfonic acid",,YUXIBTJKHLUKBD-UHFFFAOYSA-N
97,1414,"12-hydroxy-5,8,10-heptadecatrienoic acid",,KUKJHGXXZWHSBG-UHFFFAOYSA-N
98,2826718,Caspofungin,Chemical Actions and Uses;Pharmacologic Actions;Antifungal Agents;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Therapeutic Uses;Anti-Infective Agents,JYIKNQVWKBUSNH-OGZDCFRISA-N
99,91466,matrine,,ZSBXGIUJOOQZMP-JLNYLFASSA-N
100,3035635,1-(2-pyrrolidinylcarbonyl)-2-pyrrolidinylboronic acid,,XSBZZZGVAIXJLD-UHFFFAOYSA-N
101,16131215,abarelix,"Pharmacologic Actions;Chemical Actions and Uses;Hormones, Hormone Substitutes, and Hormone Antagonists;Hormone Antagonists;Physiological Effects of Drugs",AIWRTTMUVOZGPW-HSPKUQOVSA-N
102,5725,zerumbone,,GIHNTRQPEMKFKO-UHFFFAOYSA-N
103,400010,,,TXGZJQLMVSIZEI-UQMAOPSPSA-N
104,71562195,7-O-galloyltaxifolin,,KRMKNVIKYVHLTO-LEWJYISDSA-N
105,16683094,Triethyltin sulfate,,BTVURVLQSDTSSS-UHFFFAOYSA-L
106,114840,higenamine,"Adrenergic Agonists;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Hematologic Agents;Anti-Inflammatory Agents, Non-Steroidal;Fibrin Modulating Agents;Adrenergic Agents;Peripheral Nervous System Agents;Chemical Actions and Uses;Therapeutic Uses;Antirheumatic Agents;Sensory System Agents;Cardiovascular Agents;Adrenergic beta-Agonists;Analgesics;Anti-Inflammatory Agents;Specialty Uses of Chemicals;Neurotransmitter Agents;Physiological Effects of Drugs;Protective Agents;Cardiotonic Agents;Analgesics, Non-Narcotic;Fibrinolytic Agents",WZRCQWQRFZITDX-UHFFFAOYSA-N
107,447782,,,YLIQVEPMZVVUEK-UHFFFAOYSA-O
108,11600642,"3,4-dihydroxyphenyllactic acid",,PAFLSMZLRSPALU-MRVPVSSYSA-N
109,860,,,DTOSIQBPPRVQHS-UHFFFAOYSA-N
110,12585,,,QMMOXUPEWRXHJS-UHFFFAOYSA-N
111,439378,theanine,,DATAGRPVKZEWHA-YFKPBYRVSA-N
112,9825540,,,XCUWNMROWMXDLH-CKUXDGONSA-N
113,6618,tetrabromobisphenol A,,VEORPZCZECFIRK-UHFFFAOYSA-N
114,9834591,"4-aminho-2-thiabicyclo(3.1.0)hexane-4,6-dicarboxylic acid",,AVDUGNCTZRCAHH-MDASVERJSA-N
115,,,,
116,5626,"(5,6-dimethoxyindan-2-yl)dipropylamine",Dopamine Agents;Dopamine Antagonists;Pharmacologic Actions;Physiological Effects of Drugs;Molecular Mechanisms of Pharmacological Action;Chemical Actions and Uses;Neurotransmitter Agents,UOLJKAPABHXFRE-UHFFFAOYSA-N
117,5360,,,VAPNKLKDKUDFHK-UHFFFAOYSA-H
118,161784,abieslactone,,RHCAOVDBFCREAC-XOUPGTJXSA-N
119,10917,Carnitine,,PHIQHXFUZVPYII-ZCFIWIBFSA-N
120,28536,4-hydroxyhexenal,,JYTUBIHWMKQZRB-UHFFFAOYSA-N
121,153751,Aclarubicin,"Topoisomerase II Inhibitors;Antibiotics, Antineoplastic;Topoisomerase Inhibitors;Therapeutic Uses;Enzyme Inhibitors;Pharmacologic Actions;Antineoplastic Agents;Molecular Mechanisms of Pharmacological Action;Chemical Actions and Uses",KUSMIBXCRZTVML-PCCPLWKKSA-N
122,242065,4'-chloroflavanone,,WPHGNXFETYBHNT-UHFFFAOYSA-N
123,1310,"1-amino-1,3-dicarboxycyclopentane",Pharmacologic Actions;Protective Agents;Chemical Actions and Uses;Physiological Effects of Drugs;Therapeutic Uses;Neuroprotective Agents;Central Nervous System Agents,YFYNOWXBIBKGHB-UHFFFAOYSA-N
124,135235,,,IAOQCZBMCCPRDU-UHFFFAOYSA-N
125,,,,
126,157350,,,TUJKJAMUKRIRHC-UHFFFAOYSA-N
127,,,,
128,9865515,mocetinostat,Enzyme Inhibitors;Chemical Actions and Uses;Pharmacologic Actions;Histone Deacetylase Inhibitors;Molecular Mechanisms of Pharmacological Action,HRNLUBSXIHFDHP-UHFFFAOYSA-N
129,77319,,,FMDTUZFOCQKSFX-UHFFFAOYSA-N
130,5311181,Iloprost,Vasodilator Agents;Platelet Aggregation Inhibitors;Pharmacologic Actions;Cardiovascular Agents;Chemical Actions and Uses;Hematologic Agents;Therapeutic Uses,HIFJCPQKFCZDDL-ACWOEMLNSA-N
131,11445168,,,ZDFOCDTXDPKJKA-UHFFFAOYSA-N
132,137,Aminolevulinic Acid,Photosensitizing Agents;Therapeutic Uses;Chemical Actions and Uses;Pharmacologic Actions;Radiation-Sensitizing Agents;Dermatologic Agents,ZGXJTSGNIOSYLO-UHFFFAOYSA-N
133,1894360,,,DTZDSNQYNPNCPK-UHFFFAOYSA-P
134,673,dimethylglycine,,FFDGPVCHZBVARC-UHFFFAOYSA-N
135,56841936,Kaolin,Therapeutic Uses;Antidiarrheals;Pharmacologic Actions;Chemical Actions and Uses;Gastrointestinal Agents,NLYAJNPCOHFWQQ-UHFFFAOYSA-N
136,28558,beta-N-methylamino-L-alanine,Molecular Mechanisms of Pharmacological Action;Physiological Effects of Drugs;Chemical Actions and Uses;Pharmacologic Actions;Excitatory Amino Acid Agonists;Excitatory Amino Acid Agents;Neurotransmitter Agents,UJVHVMNGOZXSOZ-UHFFFAOYSA-N
137,4273754,JHW 015,"Cannabinoid Receptor Modulators;Chemical Actions and Uses;Physiological Effects of Drugs;Molecular Mechanisms of Pharmacological Action;Cannabinoid Receptor Agonists;Pharmacologic Actions;Neurotransmitter Agents;Hormones;Hormones, Hormone Substitutes, and Hormone Antagonists",LJSBBBWQTLXQEN-UHFFFAOYSA-N
138,5040205,"3,5-dihydroxy-4'-methoxystilbene",,IHVRWFJGOIWMGC-UHFFFAOYSA-N
139,179536,"3,4-dihydroxyphenyllactic acid",,PAFLSMZLRSPALU-QMMMGPOBSA-N
140,23723,Erythrityl Tetranitrate,Chemical Actions and Uses;Pharmacologic Actions;Cardiovascular Agents;Therapeutic Uses;Vasodilator Agents,SNFOERUNNSHUGP-UHFFFAOYSA-N
141,107985,triptolide,"Reproductive Control Agents;Physiological Effects of Drugs;Immunosuppressive Agents;Noxae;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Antineoplastic Agents, Alkylating;Alkylating Agents;Contraceptive Agents, Male;Chemical Actions and Uses;Toxic Actions;Antispermatogenic Agents;Contraceptive Agents;Immunologic Factors;Antineoplastic Agents;Therapeutic Uses",DFBIRQPKNDILPW-CIVMWXNOSA-N
142,125105,"Phosphatidylinositol 4,5-Diphosphate",,VQSJAWPFQCXIOB-VODLGYORSA-N
143,5310984,"4-aminopyrrolidine-2,4-dicarboxylic acid",,XZFMJVJDSYRWDQ-AWFVSMACSA-N
144,1732,chlorocresol,"Chemical Actions and Uses;Pesticides;Specialty Uses of Chemicals;Agrochemicals;Toxic Actions;Fungicides, Industrial",CFKMVGJGLGKFKI-UHFFFAOYSA-N
145,9808022,BAY 58-2667,,WPYWMXNXEZFMAK-UHFFFAOYSA-N
146,5280483,Vitamin K 1,Antifibrinolytic Agents;Micronutrients;Pharmacologic Actions;Physiological Effects of Drugs;Coagulants;Molecular Mechanisms of Pharmacological Action;Chemical Actions and Uses;Nutrients;Hematologic Agents;Growth Substances;Vitamins;Hemostatics;Fibrin Modulating Agents;Therapeutic Uses,MBWXNTAXLNYFJB-LKUDQCMESA-N
147,5589,,,DFBIRQPKNDILPW-UHFFFAOYSA-N
148,251,,,RCNSAJSGRJSBKK-UHFFFAOYSA-N
149,5362129,Ramipril,Pharmacologic Actions;Cardiovascular Agents;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Therapeutic Uses;Antihypertensive Agents;Chemical Actions and Uses;Angiotensin-Converting Enzyme Inhibitors;Protease Inhibitors,HDACQVRGBOVJII-JBDAPHQKSA-N
150,24480,manganese chloride,,GLFNIEUTAYBVOC-UHFFFAOYSA-L
151,37248,"2,5,2',5'-tetrachlorobiphenyl",,HCWZEPKLWVAEOV-UHFFFAOYSA-N
152,2142,,,LKCWBDHBTVXHDL-UHFFFAOYSA-N
153,2207,2-amino-4-phosphonobutyric acid,Anticonvulsants;Central Nervous System Agents;Chemical Actions and Uses;Excitatory Amino Acid Agents;Excitatory Amino Acid Agonists;Molecular Mechanisms of Pharmacological Action;Neurotransmitter Agents;Pharmacologic Actions;Physiological Effects of Drugs;Therapeutic Uses,DDOQBQRIEWHWBT-UHFFFAOYSA-N
154,10255,Kainic Acid,Anthelmintics;Anti-Infective Agents;Antinematodal Agents;Antiparasitic Agents;Chemical Actions and Uses;Excitatory Amino Acid Agents;Excitatory Amino Acid Agonists;Molecular Mechanisms of Pharmacological Action;Neurotransmitter Agents;Pharmacologic Actions;Physiological Effects of Drugs;Therapeutic Uses,VLSMHEGGTFMBBZ-OOZYFLPDSA-N
155,5281617,genkwanin,,JPMYFOBNRRGFNO-UHFFFAOYSA-N
156,123623,,,OGUJBRYAAJYXQP-CPYUAZPCSA-N
157,93091,titanium nitride,,NRTOMJZYCJJWKI-UHFFFAOYSA-N
158,4553,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,"Analgesics;Anti-Inflammatory Agents;Cyclooxygenase Inhibitors;Sensory System Agents;Chemical Actions and Uses;Pharmacologic Actions;Therapeutic Uses;Antirheumatic Agents;Analgesics, Non-Narcotic;Molecular Mechanisms of Pharmacological Action;Anti-Inflammatory Agents, Non-Steroidal;Physiological Effects of Drugs;Enzyme Inhibitors;Peripheral Nervous System Agents",KTDZCOWXCWUPEO-UHFFFAOYSA-N
159,40539,Quisqualic Acid,Excitatory Amino Acid Agents;Neurotransmitter Agents;Physiological Effects of Drugs;Molecular Mechanisms of Pharmacological Action;Excitatory Amino Acid Agonists;Pharmacologic Actions;Chemical Actions and Uses,ASNFTDCKZKHJSW-REOHCLBHSA-N
160,71315856,,,DPFYBZWSVVKNPZ-AQWIXGDGSA-N
161,55466,Gadolinium DTPA,Diagnostic Uses of Chemicals;Contrast Media;Chemical Actions and Uses;Specialty Uses of Chemicals;Pharmacologic Actions,LGMLJQFQKXPRGA-VPVMAENOSA-K
162,9732,4-fluorophenol,,RHMPLDJJXGPMEX-UHFFFAOYSA-N
163,5249,,,GFWRVVCDTLRWPK-UHFFFAOYSA-N
164,131350,saintopin,,CGFVUVWMYIHGHS-UHFFFAOYSA-N
165,60846,Valsartan,Angiotensin II Type 1 Receptor Blockers;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Therapeutic Uses;Cardiovascular Agents;Antihypertensive Agents;Angiotensin Receptor Antagonists,ACWBQPMHZXGDFX-QFIPXVFZSA-N
166,3780,,,MOYKHGMNXAOIAT-UHFFFAOYSA-N
167,739,,,MSWZFWKMSRAUBD-UHFFFAOYSA-N
168,42948,"2,4,5,2',4',5'-hexabromobiphenyl",,HMBBJSKXDBUNNT-UHFFFAOYSA-N
169,1930,oleylamide,Pharmacologic Actions;Chemical Actions and Uses;Food Additives;Physiological Effects of Drugs;Central Nervous System Agents;Therapeutic Uses;Food Ingredients;Hypnotics and Sedatives;Specialty Uses of Chemicals;Central Nervous System Depressants,FATBGEAMYMYZAF-UHFFFAOYSA-N
170,73333,amperozide,Psychotropic Drugs;Serotonin Agents;Central Nervous System Agents;Antipsychotic Agents;Therapeutic Uses;Neurotransmitter Agents;Chemical Actions and Uses;Central Nervous System Depressants;Tranquilizing Agents;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Serotonin Antagonists;Physiological Effects of Drugs,NNAIYOXJNVGUOM-UHFFFAOYSA-N
171,2249,Atenolol,Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Adrenergic beta-1 Receptor Antagonists;Chemical Actions and Uses;Therapeutic Uses;Autonomic Agents;Peripheral Nervous System Agents;Neurotransmitter Agents;Anti-Arrhythmia Agents;Physiological Effects of Drugs;Adrenergic beta-Antagonists;Antihypertensive Agents;Cardiovascular Agents;Sympatholytics;Adrenergic Antagonists;Adrenergic Agents,METKIMKYRPQLGS-UHFFFAOYSA-N
172,2513,Cacodylic Acid,Agrochemicals;Specialty Uses of Chemicals;Toxic Actions;Pesticides;Herbicides;Chemical Actions and Uses,OGGXGZAMXPVRFZ-UHFFFAOYSA-N
173,15139,fluanisone,Pharmacologic Actions;Tranquilizing Agents;Hypnotics and Sedatives;Central Nervous System Agents;Antipsychotic Agents;Central Nervous System Depressants;Chemical Actions and Uses;Physiological Effects of Drugs;Therapeutic Uses;Psychotropic Drugs,IRYFCWPNDIUQOW-UHFFFAOYSA-N
174,44580018,,,BYTPMMJRDFCGKX-GJRFZWDISA-N
175,7189,,,DQFBYFPFKXHELB-UHFFFAOYSA-N
176,1615,"N-Methyl-3,4-methylenedioxyamphetamine",Pharmacologic Actions;Adrenergic Agents;Psychotropic Drugs;Membrane Transport Modulators;Molecular Mechanisms of Pharmacological Action;Adrenergic Uptake Inhibitors;Hallucinogens;Central Nervous System Agents;Physiological Effects of Drugs;Chemical Actions and Uses;Neurotransmitter Uptake Inhibitors;Therapeutic Uses;Serotonin Agents;Neurotransmitter Agents,SHXWCVYOXRDMCX-UHFFFAOYSA-N
177,11698643,1-(3-(2-pyrrolidinylethoxy)phenyl)-3-((3-(trifluoromethyl)phenyl)azamethylene)benzo(d)azolin-2-one,,HXCJZIBJTFITNI-UHFFFAOYSA-N
178,2876,,,MZIOEPIEDDJOPP-UHFFFAOYSA-N
179,3246390,cambinol,,RVNSQVIUFZVNAU-UHFFFAOYSA-N
180,1599,Puromycin Aminonucleoside,"Antibiotics, Antineoplastic;Antimetabolites;Antimetabolites, Antineoplastic;Antineoplastic Agents;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Noxae;Pharmacologic Actions;Therapeutic Uses;Toxic Actions",RYSMHWILUNYBFW-UHFFFAOYSA-N
181,57106630,,,XTWYTFMLZFPYCI-DGPXGRDGSA-N
182,,,,
183,558221,,,NAAJVHHFAXWBOK-UHFFFAOYSA-N
184,9937237,,,BFZKMNSQCNVFGM-UHFFFAOYSA-N
185,54313,,,HIFJCPQKFCZDDL-NYBPDPFASA-N
186,5441,,,HXQVQGWHFRNKMS-UHFFFAOYSA-L
187,6223,Gliotoxin,Chemical Actions and Uses;Immunologic Factors;Immunosuppressive Agents;Pharmacologic Actions;Physiological Effects of Drugs,FIVPIPIDMRVLAY-RBJBARPLSA-N
188,4914,Procaine,"Physiological Effects of Drugs;Anesthetics, Local;Central Nervous System Agents;Anesthetics;Pharmacologic Actions;Central Nervous System Depressants;Peripheral Nervous System Agents;Sensory System Agents;Chemical Actions and Uses;Therapeutic Uses",MFDFERRIHVXMIY-UHFFFAOYSA-N
189,69512,malvidin,,KQIKOUUKQBTQBE-UHFFFAOYSA-N
190,87279306,,,AVXZEYRIVAMKNG-PQZOIKATSA-N
191,3675,Phenelzine,Therapeutic Uses;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Antidepressive Agents;Chemical Actions and Uses;Monoamine Oxidase Inhibitors;Enzyme Inhibitors;Psychotropic Drugs;Central Nervous System Agents,RMUCZJUITONUFY-UHFFFAOYSA-N
192,2505,,,BLTCBVOJNNKFKC-UHFFFAOYSA-N
193,33032,Glutamic Acid,,WHUUTDBJXJRKMK-VKHMYHEASA-N
194,5280885,"9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2",Antiviral Agents;Antineoplastic Agents;Chemical Actions and Uses;Pharmacologic Actions;Anti-Infective Agents;Therapeutic Uses,TUXFWOHFPFBNEJ-GJGHEGAFSA-N
195,11524144,dorsomorphin,Chemical Actions and Uses;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Protein Kinase Inhibitors,XHBVYDAKJHETMP-UHFFFAOYSA-N
196,,,,
197,10198228,1-(2-pyrrolidinylcarbonyl)-2-pyrrolidinylboronic acid,,XSBZZZGVAIXJLD-YUMQZZPRSA-N
198,16132042,Alamethicin,Pharmacologic Actions;Uncoupling Agents;Membrane Transport Modulators;Chemical Actions and Uses;Therapeutic Uses;Specialty Uses of Chemicals;Anti-Bacterial Agents;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Anti-Infective Agents;Ionophores,LGHSQOCGTJHDIL-UTXLBGCNSA-N
199,72429,leupeptin,Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action;Protease Inhibitors;Enzyme Inhibitors;Cysteine Proteinase Inhibitors;Chemical Actions and Uses,GDBQQVLCIARPGH-ULQDDVLXSA-N
200,3246569,,,QMLSMSICNBXNLJ-YUPRTTJUSA-N
201,7276,styrene oxide,Carcinogens;Chemical Actions and Uses;Mutagens;Toxic Actions;Noxae,AWMVMTVKBNGEAK-UHFFFAOYSA-N
202,37768,Amikacin,Therapeutic Uses;Anti-Infective Agents;Anti-Bacterial Agents;Chemical Actions and Uses;Pharmacologic Actions,LKCWBDHBTVXHDL-RMDFUYIESA-N
203,,,,
204,71191,Cromakalim,Autonomic Agents;Antihypertensive Agents;Physiological Effects of Drugs;Chemical Actions and Uses;Bronchodilator Agents;Vasodilator Agents;Respiratory System Agents;Parasympatholytics;Pharmacologic Actions;Peripheral Nervous System Agents;Cardiovascular Agents;Anti-Asthmatic Agents;Therapeutic Uses,TVZCRIROJQEVOT-LSDHHAIUSA-N
205,5578,Trimethoprim,"Cytochrome P-450 Enzyme Inhibitors;Antiparasitic Agents;Anti-Infective Agents;Antimalarials;Antiprotozoal Agents;Folic Acid Antagonists;Anti-Infective Agents, Urinary;Chemical Actions and Uses;Anti-Dyskinesia Agents;Cytochrome P-450 CYP2C8 Inhibitors;Renal Agents;Therapeutic Uses;Pharmacologic Actions;Central Nervous System Agents;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Metabolic Side Effects of Drugs and Substances",IEDVJHCEMCRBQM-UHFFFAOYSA-N
206,5281771,echinacoside,,FSBUXLDOLNLABB-ISAKITKMSA-N
207,16682999,bismuth subgallate,Hematologic Agents;Pharmacologic Actions;Hemostatics;Therapeutic Uses;Coagulants;Chemical Actions and Uses;Anti-Infective Agents,XXCBNHDMGIZPQF-UHFFFAOYSA-L
208,46915213,,,LQRJAEQXMSMEDP-BXWXCLBKSA-N
209,5518,,,HRBUJQUHXGOSQW-UHFFFAOYSA-N
210,56603730,,,UPSXYNJDCKOCFD-DEGUGSHBSA-N
211,24755482,,,NLSGUPWFZCWUGR-QVKCEAGUSA-N
212,9815559,,,XRZWVSXEDRYQGC-ZJUUUORDSA-N
213,442089,stevioside,Specialty Uses of Chemicals;Food Ingredients;Sweetening Agents;Flavoring Agents;Chemical Actions and Uses;Food Additives,UEDUENGHJMELGK-HYDKPPNVSA-N
214,19777023,,,LIEVTTYXDCZXRG-UHFFFAOYSA-N
215,6536812,ONO 1301,,WBBLIRPKRKYMTD-BYCLXTJYSA-N
216,159508,CDRI 85-287,,DBHGMZQRJDUFGS-UHFFFAOYSA-N
217,1271,(alpha-carboxycyclopropyl)glycine,Chemical Actions and Uses;Excitatory Amino Acid Agents;Excitatory Amino Acid Agonists;Molecular Mechanisms of Pharmacological Action;Neurotransmitter Agents;Pharmacologic Actions;Physiological Effects of Drugs,GZOVEPYOCJWRFC-UHFFFAOYSA-N
218,1232,1-hydroxy-3-amino-2-pyrrolidone,Excitatory Amino Acid Antagonists;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Excitatory Amino Acid Agonists;Excitatory Amino Acid Agents;Physiological Effects of Drugs;Neurotransmitter Agents;Pharmacologic Actions,HCKUBNLZMKAEIN-UHFFFAOYSA-N
219,19065601,,,IORISFYTXJVNFE-UHFFFAOYSA-N
220,5360515,Naltrexone,Central Nervous System Agents;Physiological Effects of Drugs;Pharmacologic Actions;Peripheral Nervous System Agents;Chemical Actions and Uses;Narcotic Antagonists;Alcohol Deterrents;Sensory System Agents;Therapeutic Uses,DQCKKXVULJGBQN-XFWGSAIBSA-N
221,5960,Aspartic Acid,,CKLJMWTZIZZHCS-REOHCLBHSA-N
222,3036154,alpha-galactosylceramide,,VQFKFAKEUMHBLV-VDYNBUGPSA-N
223,4850,Piribedil,Dopamine Agents;Physiological Effects of Drugs;Central Nervous System Agents;Pharmacologic Actions;Chemical Actions and Uses;Anti-Dyskinesia Agents;Molecular Mechanisms of Pharmacological Action;Neurotransmitter Agents;Therapeutic Uses;Antiparkinson Agents;Dopamine Agonists,OQDPVLVUJFGPGQ-UHFFFAOYSA-N
224,6603977,5-(4-phenylbutoxy)psoralen,,JJAWGNIQEOFURP-UHFFFAOYSA-N
225,64981,arctigenin,,NQWVSMVXKMHKTF-JKSUJKDBSA-N
226,5038,,,HDACQVRGBOVJII-UHFFFAOYSA-N
227,449005,Cardiolipins,,XVTUQDWPJJBEHJ-KZCWQMDCSA-N
228,4428,,,DQCKKXVULJGBQN-UHFFFAOYSA-N
229,11725801,sauchinone,,GMTJIWUFFXGFHH-WPAOEJHSSA-N
230,11228183,ABT-737,,HPLNQCPCUACXLM-PGUFJCEWSA-N
231,5152,Salmeterol Xinafoate,Chemical Actions and Uses;Autonomic Agents;Therapeutic Uses;Molecular Mechanisms of Pharmacological Action;Adrenergic beta-Agonists;Neurotransmitter Agents;Adrenergic Agents;Anti-Asthmatic Agents;Bronchodilator Agents;Adrenergic beta-2 Receptor Agonists;Peripheral Nervous System Agents;Pharmacologic Actions;Physiological Effects of Drugs;Respiratory System Agents;Adrenergic Agonists,GIIZNNXWQWCKIB-UHFFFAOYSA-N
232,11284169,sagopilone,Pharmacologic Actions;Therapeutic Uses;Antineoplastic Agents;Chemical Actions and Uses,BFZKMNSQCNVFGM-UCEYFQQTSA-N
233,72886,,,XVOYSCVBGLVSOL-REOHCLBHSA-N
234,3910,leupeptin,Cysteine Proteinase Inhibitors;Protease Inhibitors;Enzyme Inhibitors;Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action;Chemical Actions and Uses,GDBQQVLCIARPGH-UHFFFAOYSA-N
235,877,methacrylyl-coenzyme A,,NPALUEYCDZWBOV-UHFFFAOYSA-N
236,2459,,,VUAFHZCUKUDDBC-UHFFFAOYSA-N
237,5470187,zerumbone,,GIHNTRQPEMKFKO-SKTNYSRSSA-N
238,5280506,prostaglandin F2beta,,PXGPLTODNUVGFL-JZFBHDEDSA-N
239,5284583,Levetiracetam,Therapeutic Uses;Nootropic Agents;Anticonvulsants;Pharmacologic Actions;Chemical Actions and Uses;Central Nervous System Agents,HPHUVLMMVZITSG-LURJTMIESA-N
240,108001,"3,5-dihydroxyphenylglycine",Neurotransmitter Agents;Molecular Mechanisms of Pharmacological Action;Excitatory Amino Acid Antagonists;Pharmacologic Actions;Chemical Actions and Uses;Excitatory Amino Acid Agents;Excitatory Amino Acid Agonists;Physiological Effects of Drugs,HOOWCUZPEFNHDT-UHFFFAOYSA-N
241,9963963,G(M1) Ganglioside,,QPJBWNIQKHGLAU-IQZHVAEDSA-N
242,59708,Levetiracetam,Pharmacologic Actions;Central Nervous System Agents;Therapeutic Uses;Nootropic Agents;Chemical Actions and Uses;Anticonvulsants,HPHUVLMMVZITSG-UHFFFAOYSA-N
243,24180710,,,DTNPNBFXGDHGPM-KKUQBAQOSA-N
244,24846128,,,GZMJEZQPYGGHGJ-XIASAICYSA-N
245,56841897,microcystin,Chemical Actions and Uses;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions,SRUWWOSWHXIIIA-UKPGNTDSSA-N
246,228398,,,DATAGRPVKZEWHA-UHFFFAOYSA-N
247,6437867,DDB,,YNPIDJWKKHGXAK-ADXGFCJISA-N
248,105035,,,OSTGTTZJOCZWJG-UHFFFAOYSA-N
249,114873,,,RZWIIPASKMUIAC-VQTJNVASSA-N
250,71120,isospaglumic acid,Noxae;Autonomic Agents;Pharmacologic Actions;Histamine H1 Antagonists;Bronchodilator Agents;Neurotoxins;Toxic Actions;Histamine Antagonists;Physiological Effects of Drugs;Therapeutic Uses;Neuroprotective Agents;Neurotransmitter Agents;Histamine Agents;Molecular Mechanisms of Pharmacological Action;Anti-Asthmatic Agents;Central Nervous System Agents;Anti-Allergic Agents;Peripheral Nervous System Agents;Chemical Actions and Uses;Respiratory System Agents;Protective Agents,OPVPGKGADVGKTG-NKWVEPMBSA-N
251,4812,Vitamin K 1,Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Fibrin Modulating Agents;Coagulants;Antifibrinolytic Agents;Therapeutic Uses;Micronutrients;Vitamins;Growth Substances;Hemostatics;Hematologic Agents;Physiological Effects of Drugs;Nutrients;Pharmacologic Actions,MBWXNTAXLNYFJB-UHFFFAOYSA-N
252,309160,,,QMLSMSICNBXNLJ-UHFFFAOYSA-N
253,25701,Cysteic Acid,,XVOYSCVBGLVSOL-UHFFFAOYSA-N
254,9861304,YS 49,,YGCQFKVNIBDJFW-SFHVURJKSA-N
255,83606,,,ONYCUIABXVBCTR-UHFFFAOYSA-N
256,4364,,,PRQROPMIIGLWRP-UHFFFAOYSA-N
257,5355,Sulpiride,"Antidepressive Agents;Antidepressive Agents, Second-Generation;Antipsychotic Agents;Central Nervous System Agents;Central Nervous System Depressants;Chemical Actions and Uses;Dopamine Agents;Dopamine Antagonists;Molecular Mechanisms of Pharmacological Action;Neurotransmitter Agents;Pharmacologic Actions;Physiological Effects of Drugs;Psychotropic Drugs;Therapeutic Uses;Tranquilizing Agents",BGRJTUBHPOOWDU-UHFFFAOYSA-N
258,102399,,,FZWBNHMXJMCXLU-PPSBPDGWSA-N
259,440038,,,BJOZNDRNJJZHPZ-LUWBGTNYSA-N
260,154656,amediplase,,YQINXCSNGCDFCQ-CMOCDZPBSA-N
261,5282219,sofalcone,Gastrointestinal Agents;Therapeutic Uses;Chemical Actions and Uses;Pharmacologic Actions;Anti-Ulcer Agents,GFWRVVCDTLRWPK-KPKJPENVSA-N
262,24479,stannous chloride,,AXZWODMDQAVCJE-UHFFFAOYSA-L
263,100184,3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin,"Cross-Linking Reagents;Antibiotics, Antineoplastic;Antineoplastic Agents;Chemical Actions and Uses;Laboratory Chemicals;Pharmacologic Actions;Specialty Uses of Chemicals;Indicators and Reagents;Therapeutic Uses",YIMDLWDNDGKDTJ-UHFFFAOYSA-N
264,,,,
265,9881506,4-methylene-2-octyl-5-oxofuran-3-carboxylic acid,,VCWLZDVWHQVAJU-NEPJUHHUSA-N
266,3488,Glyburide,Chemical Actions and Uses;Hypoglycemic Agents;Physiological Effects of Drugs;Pharmacologic Actions,ZNNLBTZKUZBEKO-UHFFFAOYSA-N
267,54459,Idazoxan,Physiological Effects of Drugs;Adrenergic alpha-Antagonists;Chemical Actions and Uses;Adrenergic Agents;Neurotransmitter Agents;Pharmacologic Actions;Adrenergic alpha-2 Receptor Antagonists;Molecular Mechanisms of Pharmacological Action;Adrenergic Antagonists,HPMRFMKYPGXPEP-UHFFFAOYSA-N
268,156665,eglumetad,Neurotransmitter Agents;Excitatory Amino Acid Agonists;Central Nervous System Agents;Tranquilizing Agents;Excitatory Amino Acid Agents;Central Nervous System Depressants;Pharmacologic Actions;Physiological Effects of Drugs;Molecular Mechanisms of Pharmacological Action;Psychotropic Drugs;Therapeutic Uses;Anti-Anxiety Agents;Chemical Actions and Uses,XJPQOSJARVVBIU-PLFKSMQJSA-N
269,3150,,,VZFRNCSOCOPNDB-UHFFFAOYSA-N
270,6053,p-Dimethylaminoazobenzene,Carcinogens;Noxae;Chemical Actions and Uses;Specialty Uses of Chemicals;Coloring Agents;Toxic Actions,JCYPECIVGRXBMO-UHFFFAOYSA-N
271,9877229,bleomycin A6,,FOUFFVYWFNBHHH-YNGSZULRSA-N
272,24762199,,,LVTAJNYOAFOKTA-JMSWFPOCSA-N
273,408895,,,YLWVQFBYKLFJMB-UHFFFAOYSA-N
274,67111,,,RGNXWPVNPFAADO-UHFFFAOYSA-N
275,161557,ampelopsin,,KJXSIXMJHKAJOD-LSDHHAIUSA-N
276,24766,Chondroitin Sulfates,,KXKPYJOVDUMHGS-OSRGNVMNSA-N
277,67361,,,HXQVQGWHFRNKMS-UHFFFAOYSA-M
278,939,,,DAYLJWODMCOQEW-UHFFFAOYSA-O
279,3016734,N-bromotaurine,,USAWSWBIFACPGD-UHFFFAOYSA-N
280,134071,KM 1146,,AUPNGGXXLZJAHC-UHFFFAOYSA-N
281,4171,Metoprolol,Adrenergic beta-1 Receptor Antagonists;Pharmacologic Actions;Adrenergic Agents;Autonomic Agents;Adrenergic beta-Antagonists;Chemical Actions and Uses;Sympatholytics;Anti-Arrhythmia Agents;Molecular Mechanisms of Pharmacological Action;Cardiovascular Agents;Peripheral Nervous System Agents;Antihypertensive Agents;Physiological Effects of Drugs;Therapeutic Uses;Adrenergic Antagonists;Neurotransmitter Agents,IUBSYMUCCVWXPE-UHFFFAOYSA-N
282,3485,Glutaral,Cross-Linking Reagents;Pharmacologic Actions;Specialty Uses of Chemicals;Anti-Infective Agents;Indicators and Reagents;Therapeutic Uses;Laboratory Chemicals;Disinfectants;Chemical Actions and Uses;Fixatives,SXRSQZLOMIGNAQ-UHFFFAOYSA-N
283,2008,Aclarubicin,"Antibiotics, Antineoplastic;Antineoplastic Agents;Chemical Actions and Uses;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Therapeutic Uses;Topoisomerase II Inhibitors;Topoisomerase Inhibitors",USZYSDMBJDPRIF-UHFFFAOYSA-N
284,91690,tetcyclacis,Chemical Actions and Uses;Metabolic Side Effects of Drugs and Substances;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Cytochrome P-450 Enzyme Inhibitors,DPOWHSMECVNHAT-UHFFFAOYSA-N
285,10591,,,BHTRKEVKTKCXOH-XZWNYQJKSA-N
286,55480,,,XNCDYJFPRPDERF-PBCQUBLHSA-N
287,2729,Chlorprothixene,Antipsychotic Agents;Central Nervous System Depressants;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Tranquilizing Agents;Dopamine Antagonists;Central Nervous System Agents;Physiological Effects of Drugs;Psychotropic Drugs;Therapeutic Uses;Dopamine Agents;Neurotransmitter Agents,WSPOMRSOLSGNFJ-UHFFFAOYSA-N
288,4545574,,,JRQRKFDFHAPMGQ-UHFFFAOYSA-N
289,87379454,,,AVXZEYRIVAMKNG-UHFFFAOYSA-N
290,165390,methacrylyl-coenzyme A,,NPALUEYCDZWBOV-NDZSKPAWSA-N
291,9929731,"2,2-dichloro-12-(p-chlorophenyl)-dodecanoic acid",,GPCJDSXBRMKASP-UHFFFAOYSA-N
292,2803,Clonidine,Physiological Effects of Drugs;Chemical Actions and Uses;Analgesics;Peripheral Nervous System Agents;Adrenergic Agents;Adrenergic alpha-2 Receptor Agonists;Adrenergic Agonists;Cardiovascular Agents;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Sympatholytics;Central Nervous System Agents;Antihypertensive Agents;Adrenergic alpha-Agonists;Autonomic Agents;Neurotransmitter Agents;Sensory System Agents;Therapeutic Uses,GJSURZIOUXUGAL-UHFFFAOYSA-N
293,9868580,biphenyl-indanone A,,KMKBEESNZAPKMP-UHFFFAOYSA-N
294,5483658,,,FOUFFVYWFNBHHH-OIKIRKRFSA-N
295,29539,N-hydroxyphenacetin,,GPMYDZBSYQUDJZ-UHFFFAOYSA-N
296,5018,SCH 23390,,GOTMKOSCLKVOGG-UHFFFAOYSA-N
297,709,,,KSEBMYQBYZTDHS-UHFFFAOYSA-N
298,155773,Xamoterol,Adrenergic Agonists;Adrenergic beta-Agonists;Molecular Mechanisms of Pharmacological Action;Physiological Effects of Drugs;Adrenergic beta-1 Receptor Agonists;Chemical Actions and Uses;Pharmacologic Actions;Adrenergic Agents;Neurotransmitter Agents,QEDVGROSOZBGOZ-UHFFFAOYSA-N
299,245005,Aconitine,"Voltage-Gated Sodium Channel Agonists;Molecular Mechanisms of Pharmacological Action;Immunologic Factors;Pharmacologic Actions;Membrane Transport Modulators;Adjuvants, Immunologic;Sodium Channel Agonists;Physiological Effects of Drugs;Chemical Actions and Uses",XFSBVAOIAHNAPC-XTHSEXKGSA-N
300,115271,DDB,,YNPIDJWKKHGXAK-UHFFFAOYSA-N
301,5281654,3-methylquercetin,,IZQSVPBOUDKVDZ-UHFFFAOYSA-N
302,160512,ar-turmerone,,NAAJVHHFAXWBOK-ZDUSSCGKSA-N
303,24287,stannic chloride,,HPGGPRDJHPYFRM-UHFFFAOYSA-J
304,442653,,,VABYUUZNAVQNPG-UHFFFAOYSA-N
305,5281295,sulfuretin,,RGNXWPVNPFAADO-NSIKDUERSA-N
306,2012,Aconitine,"Adjuvants, Immunologic;Chemical Actions and Uses;Immunologic Factors;Membrane Transport Modulators;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Physiological Effects of Drugs;Sodium Channel Agonists;Voltage-Gated Sodium Channel Agonists",XFSBVAOIAHNAPC-UHFFFAOYSA-N
307,14180,Nicotinamide Mononucleotide,,DAYLJWODMCOQEW-TURQNECASA-N
308,124219,rubimaillin,,VLGATXOTCNBWIT-UHFFFAOYSA-N
309,9804719,,,LNDPHUOSLCCHHY-PYJNHQTQSA-N
310,5283387,oleylamide,Food Ingredients;Chemical Actions and Uses;Therapeutic Uses;Pharmacologic Actions;Central Nervous System Agents;Specialty Uses of Chemicals;Hypnotics and Sedatives;Physiological Effects of Drugs;Food Additives;Central Nervous System Depressants,FATBGEAMYMYZAF-KTKRTIGZSA-N
311,2370,Bethanechol,Neurotransmitter Agents;Autonomic Agents;Molecular Mechanisms of Pharmacological Action;Muscarinic Agonists;Parasympathomimetics;Chemical Actions and Uses;Cholinergic Agents;Physiological Effects of Drugs;Pharmacologic Actions;Cholinergic Agonists;Peripheral Nervous System Agents,NZUPCNDJBJXXRF-UHFFFAOYSA-O
312,20138,,,MLUCVPSAIODCQM-UHFFFAOYSA-N
313,186,acetyl phosphate,,LIPOUNRJVLNBCD-UHFFFAOYSA-N
314,656744,,,LELVHAQTWXTCLY-UHFFFAOYSA-N
315,123871,6-hydroxydopa quinone,,YWRFBISQAMHSIX-YFKPBYRVSA-N
316,5476815,,,VWEYNEFKXXWVHZ-RSPUIOJXSA-N
317,17757205,,,ZDFOCDTXDPKJKA-WJOKGBTCSA-N
318,16104907,subamolide B,,YLCXJNOKPGBEPM-DPBVHHOFSA-N
319,5460037,Dextrans,Hematologic Agents;Plasma Substitutes;Anticoagulants;Blood Substitutes;Chemical Actions and Uses;Therapeutic Uses;Pharmacologic Actions,FZWBNHMXJMCXLU-BLAUPYHCSA-N
320,3052762,prucalopride,Pharmacologic Actions;Therapeutic Uses;Physiological Effects of Drugs;Laxatives;Serotonin Agents;Gastrointestinal Agents;Serotonin Receptor Agonists;Molecular Mechanisms of Pharmacological Action;Serotonin 5-HT4 Receptor Agonists;Chemical Actions and Uses;Neurotransmitter Agents,ZPMNHBXQOOVQJL-UHFFFAOYSA-N
321,9817980,,,WTHURCRQFHKJKU-UHFFFAOYSA-N
322,5587,Tripelennamine,Histamine Agents;Therapeutic Uses;Chemical Actions and Uses;Physiological Effects of Drugs;Neurotransmitter Agents;Pharmacologic Actions;Histamine Antagonists;Molecular Mechanisms of Pharmacological Action;Histamine H1 Antagonists;Anti-Allergic Agents,UFLGIAIHIAPJJC-UHFFFAOYSA-N
323,10374453,,,MOTMGLITKDYJPL-UHFFFAOYSA-N
324,5283314,4-hydroxyhexenal,,JYTUBIHWMKQZRB-ONEGZZNKSA-N
325,2518,,,QAIPRVGONGVQAS-UHFFFAOYSA-N
326,2471,Bumetanide,Membrane Transport Modulators;Chemical Actions and Uses;Physiological Effects of Drugs;Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action;Natriuretic Agents;Diuretics;Sodium Potassium Chloride Symporter Inhibitors,MAEIEVLCKWDQJH-UHFFFAOYSA-N
327,768,Hydrogen Cyanide,Chemical Warfare Agents;Chemical Actions and Uses;Poisons;Specialty Uses of Chemicals;Toxic Actions;Noxae,LELOWRISYMNNSU-UHFFFAOYSA-N
328,2866,,,BLGXFZZNTVWLAY-UHFFFAOYSA-N
329,46184563,,,JSTZMWXBGOXHSZ-CGHXCNIISA-N
330,73592,,,FBSKJMQYURKNSU-QJDQKFITSA-N
331,128016,HX 600,,DLFBCHSYAZBTSS-UHFFFAOYSA-N
332,6255462,4'-methoxyresveratrol,,IHVRWFJGOIWMGC-NSCUHMNNSA-N
333,1574,2-methyl-5-HT,,WYWNEDARFVJQSG-UHFFFAOYSA-N
334,440735,eriodictyol,,SBHXYTNGIZCORC-ZDUSSCGKSA-N
335,6020,Puromycin Aminonucleoside,"Antibiotics, Antineoplastic;Antineoplastic Agents;Molecular Mechanisms of Pharmacological Action;Chemical Actions and Uses;Antimetabolites;Antimetabolites, Antineoplastic;Noxae;Pharmacologic Actions;Therapeutic Uses;Toxic Actions",RYSMHWILUNYBFW-GRIPGOBMSA-N
336,667467,Chlorprothixene,Psychotropic Drugs;Therapeutic Uses;Pharmacologic Actions;Dopamine Agents;Chemical Actions and Uses;Central Nervous System Agents;Physiological Effects of Drugs;Antipsychotic Agents;Tranquilizing Agents;Neurotransmitter Agents;Central Nervous System Depressants;Dopamine Antagonists;Molecular Mechanisms of Pharmacological Action,WSPOMRSOLSGNFJ-AUWJEWJLSA-N
337,16158207,linaclotide,Pharmacologic Actions;Chemical Actions and Uses;Therapeutic Uses;Enzyme Activators;Molecular Mechanisms of Pharmacological Action;Gastrointestinal Agents;Guanylyl Cyclase C Agonists,KWFNVZFWXXEJKL-YZDVLOIKSA-N
338,3008868,dieckol,,DRZQFGYIIYNNEC-UHFFFAOYSA-N
339,189460,,,MGBKJKDRMRAZKC-UHFFFAOYSA-N
340,3816,,,VLSMHEGGTFMBBZ-UHFFFAOYSA-N
341,10221200,,,QLZOWJNFLXSDSH-UHFFFAOYSA-N
342,5462310,,,OKTJSMMVPCPJKN-UHFFFAOYSA-N
343,40828,diisopropanolnitrosamine,Toxic Actions;Carcinogens;Mutagens;Noxae;Chemical Actions and Uses,MNIGYIKCFSPQRJ-UHFFFAOYSA-N
344,73755113,tin protoporphyrin IX,Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Enzyme Inhibitors;Chemical Actions and Uses,VWEYNEFKXXWVHZ-IBPJAKCHSA-N
345,38012,"2,2',3,5',6-pentachlorobiphenyl",,GXNNLIMMEXHBKV-UHFFFAOYSA-N
346,156288,,,MGOKSQNXXRPCMD-UHFFFAOYSA-N
347,11095,,,SBHXYTNGIZCORC-UHFFFAOYSA-N
348,5650,,,ACWBQPMHZXGDFX-UHFFFAOYSA-N
349,4385592,"2-(2,3-dicarboxycyclopropyl)glycine",Central Nervous System Agents;Pharmacologic Actions;Anticonvulsants;Chemical Actions and Uses;Therapeutic Uses,MATPZHBYOVDBLI-UHFFFAOYSA-N
350,689043,caffeic acid,Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Physiological Effects of Drugs;Specialty Uses of Chemicals;Antioxidants;Chemical Actions and Uses;Protective Agents,QAIPRVGONGVQAS-DUXPYHPUSA-N
351,449219,,,XKMGDFKROIEADD-CIOUUCGESA-N
352,387042,NSC 680410,,YJZSUCFGHXQWDM-UHFFFAOYSA-N
353,290380,,,ACEAELOMUCBPJP-UHFFFAOYSA-N
354,439177,Glycogen,,BYSGBSNPRWKUQH-UJDJLXLFSA-N
355,5312765,"12-hydroxy-5,8,10-heptadecatrienoic acid",,KUKJHGXXZWHSBG-GMPNNLDHSA-N
356,91195,"(1R,5S)-4-methyl-1-propan-2-ylbicyclo(3.1.0)hex-3-en-2-one",,LTTVJAQLCIHAFV-UHFFFAOYSA-N
357,24425,chromic acid,,KRVSOGSZCMJSLX-UHFFFAOYSA-L
358,11966249,Carrageenan,,ZNOZWUKQPJXOIG-XSBHQQIPSA-L
359,107992,6-chloro-2-(1-piperazinyl)pyrazine,Pharmacologic Actions;Neurotransmitter Agents;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Serotonin Agents;Serotonin Receptor Agonists;Physiological Effects of Drugs,CJAWPFJGFFNXQI-UHFFFAOYSA-N
360,59239114,,,WQBAZXIQANTUOY-KRWDZBQOSA-N
361,253602,Anisomycin,Anti-Bacterial Agents;Anti-Infective Agents;Antiparasitic Agents;Antiprotozoal Agents;Chemical Actions and Uses;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Nucleic Acid Synthesis Inhibitors;Pharmacologic Actions;Protein Synthesis Inhibitors;Therapeutic Uses,YKJYKKNCCRKFSL-RDBSUJKOSA-N
362,3586141,,,WMYQZGAEYLPOSX-UHFFFAOYSA-N
363,16136245,acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide,,MEUCPCLKGZSHTA-XYAYPHGZSA-N
364,213037,5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide,Enzyme Activators;Pharmacologic Actions;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action,PQHLRGARXNPFCF-UHFFFAOYSA-N
365,,,,
366,611,Glutamic Acid,,WHUUTDBJXJRKMK-UHFFFAOYSA-N
367,5291488,,,PEFNSGRTCBGNAN-UHFFFAOYSA-N
368,9297,Allylisopropylacetamide,,HINLFAQOKAHXOD-UHFFFAOYSA-N
369,5255,,,OPVPGKGADVGKTG-UHFFFAOYSA-N
370,104766,"1-amino-1,3-dicarboxycyclopentane",Central Nervous System Agents;Therapeutic Uses;Chemical Actions and Uses;Protective Agents;Pharmacologic Actions;Neuroprotective Agents;Physiological Effects of Drugs,YFYNOWXBIBKGHB-FBCQKBJTSA-N
371,4248455,,,VCWLZDVWHQVAJU-UHFFFAOYSA-N
372,12544,Glycochenodeoxycholic Acid,Specialty Uses of Chemicals;Surface-Active Agents;Detergents;Chemical Actions and Uses,GHCZAUBVMUEKKP-GYPHWSFCSA-N
373,23915,schizandrin,,YEFOAORQXAOVJQ-UHFFFAOYSA-N
374,10030106,,,BYTPMMJRDFCGKX-CZDRXDAJSA-N
375,92396,tetcyclacis,,DPOWHSMECVNHAT-YERPJTIDSA-N
376,3365422,,,LQRZCSNQDRKLNN-UHFFFAOYSA-R
377,35319,asperlin,,SPKNARKFCOPTSY-UHFFFAOYSA-N
378,5976,dimazine,,RHUYHJGZWVXEHW-UHFFFAOYSA-N
379,15491250,,,HSOKCKRDVRKPGT-UHFFFAOYSA-N
380,5281800,acteoside,"Antineoplastic Agents, Phytogenic;Anti-Infective Agents;Pharmacologic Actions;Specialty Uses of Chemicals;Antioxidants;Physiological Effects of Drugs;Therapeutic Uses;Chelating Agents;Antineoplastic Agents;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Immunosuppressive Agents;Protective Agents;Immunologic Factors;Sequestering Agents",FBSKJMQYURKNSU-ZLSOWSIRSA-N
381,86664385,,,ABIGASPCHXKGDP-UHFFFAOYSA-N
382,6883,Isosorbide Dinitrate,Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Chemical Actions and Uses;Nitric Oxide Donors;Cardiovascular Agents;Therapeutic Uses;Vasodilator Agents,MOYKHGMNXAOIAT-JGWLITMVSA-N
383,23982,Gadolinium,,UIWYJDYFSGRHKR-UHFFFAOYSA-N
384,11006,n-hexadecane,,DCAYPVUWAIABOU-UHFFFAOYSA-N
385,2199,,,YKJYKKNCCRKFSL-UHFFFAOYSA-N
386,287064,"methyl 3,4-dihydroxybenzoate",,CUFLZUDASVUNOE-UHFFFAOYSA-N
387,5354027,"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid",Cardiovascular Agents;Chemical Actions and Uses;Therapeutic Uses;Pharmacologic Actions;Vasoconstrictor Agents,LQANGKSBLPMBTJ-RTYMFESYSA-N
388,104742,,,HPZJMUBDEAMBFI-HSQYWUDLSA-N
389,5462471,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-","Analgesics;Analgesics, Opioid;Anti-Arrhythmia Agents;Cardiovascular Agents;Central Nervous System Agents;Central Nervous System Depressants;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Narcotics;Neurotransmitter Agents;Peripheral Nervous System Agents;Pharmacologic Actions;Physiological Effects of Drugs;Sensory System Agents;Therapeutic Uses",HPZJMUBDEAMBFI-WTNAPCKOSA-N
390,892,scyllitol,,CDAISMWEOUEBRE-UHFFFAOYSA-N
391,242994,stevioside,Chemical Actions and Uses;Food Ingredients;Specialty Uses of Chemicals;Sweetening Agents;Flavoring Agents;Food Additives,UEDUENGHJMELGK-DROKWKKMSA-N
